MYX mayne pharma group limited

Charts never backed his/her ramping with any logical financial...

  1. 2,540 Posts.
    lightbulb Created with Sketch. 746
    Charts never backed his/her ramping with any logical financial analysis - a clear sign he/she had no idea what they were talking about. On a few occasions I challenged his/her statements, but never was afforded a response.

    If you're going to ramp, back it up with some numbers.

    The only numbers I keep seeing on MYX's statements are ongoing yearly losses and shrinking shareholder equity, along with massive write downs, grossly overpaid acquisitions and falling revenue. Back when the share price was hovering around the $1.00 mark I questioned the (what I perceived as) overvalued market cap, but was hastily shut down, so never raised my head again (but was watching on the sidelines). Management have not helped themselves either - the lack of enthusiasm and plans for growth/turnaround is very worrying, and doesn't provide an investor confidence in equity appreciation.

    Lets see what this year's financial results bring - not long to find out now. More of the above will see the stock-price hammered to new lows IMO.

    Cheers.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
$5.08
Change
0.010(0.20%)
Mkt cap ! $412.7M
Open High Low Value Volume
$5.13 $5.15 $5.08 $445.2K 87.01K

Buyers (Bids)

No. Vol. Price($)
1 810 $5.08
 

Sellers (Offers)

Price($) Vol. No.
$5.15 2033 2
View Market Depth
Last trade - 16.10pm 27/06/2025 (20 minute delay) ?
MYX (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.